More than 2 decades of treating atypical fibroxanthoma at mayo clinic: what have we learned from 91 patients?

Dermatol Surg. 2009 May;35(5):765-72. doi: 10.1111/j.1524-4725.2009.01126.x. Epub 2008 Mar 23.

Abstract

Background: Atypical fibroxanthoma (AFX) typically occurs on the head and neck of elderly white men. Usually considered a malignancy, it is treated with wide local excision (WLE) or total margin control using Mohs micrographic surgery (MMS).

Objective: To determine the most appropriate treatment for this tumor based on a review of cases treated at Mayo Clinic.

Methods: We reviewed the medical records of patients with AFX treated at Mayo Clinic from 1980 to 2004.

Results: We identified 91 patients with 93 tumors. Treatment information was available for 88 tumors (59 treated with MMS, 23 with WLE, and 6 by other means). There were no recurrences in the patients treated with MMS, with a median follow-up of 4.5 years (range 1.0-16.1 years). Two patients treated with WLE had single recurrences, with a median follow-up of 8.7 years (range 1.5-26.3 years).

Conclusions: Total microscopic margin control using MMS was the most effective means of treating AFX.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biopsy
  • Diagnosis, Differential
  • Female
  • Follow-Up Studies
  • Head and Neck Neoplasms / pathology
  • Head and Neck Neoplasms / surgery*
  • Histiocytoma, Benign Fibrous / pathology
  • Histiocytoma, Benign Fibrous / surgery*
  • Hospitals, University*
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Minnesota / epidemiology
  • Mohs Surgery / methods*
  • Neoplasm Recurrence, Local / epidemiology
  • Retrospective Studies
  • Skin Neoplasms / pathology
  • Skin Neoplasms / surgery*
  • Time Factors
  • Treatment Outcome
  • Xanthomatosis / pathology
  • Xanthomatosis / surgery*